Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors

NCT02379416 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

NIH

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Nilotinib + Paclitaxel

Sponsor

National Cancer Institute (NCI)